Joint with: Neurodegeneration: From Neurocentric to System-Wide Perspectives
Neuroinflammation in Health and Disease
Jun 22–25, 2026 | Fairmont Chateau Whistler, Whistler, BC, Canada
Scientific Organizers:
Michael V. Sofroniew, Malu G. Tansey and Robyn S Klein
In Person
On Demand
Jun 22–25, 2026 | Fairmont Chateau Whistler, Whistler, BC, Canada
Scientific Organizers:
Michael V. Sofroniew, Malu G. Tansey and Robyn S Klein
Available Formats:
Supported by the Directors' Fund
In Person
On Demand
Available Formats: = In Person = On Demand
Monday, June 22, 2026
Booking Function
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Tuesday, June 23, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Session (Joint)
8:00–9:30 AM
Randall Bateman †, Washington University School of Medicine
Amyloid, tau, Neurodegeneration, Inflammation in AD
Amyloid, tau, Neurodegeneration, Inflammation in AD
Astrid Iversen, University of Oxford
Genomic Risk for Neuroinflammation
Genomic Risk for Neuroinflammation
Coffee Break
9:30–9:50 AM
Integrating Clinical Experience with Biology and Mechanism (Joint)
9:30–11:15 AM
Malu G. Tansey, University of Florida
Role of Central-Peripheral Neuroimmune Cross-Talk in Neurodegeneration
Role of Central-Peripheral Neuroimmune Cross-Talk in Neurodegeneration
Christian Haass, Ludwig-Maximilians University Munich
Modulation of Microglial Function
Modulation of Microglial Function
Short Talk(s) Chosen from Abstracts
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Symposia Spotlight: Late-breaking research presentations selected from abstract submissions
2:30–4:30 PM
Short Talk(s) Chosen from Abstracts
Coffee Available
4:30–5:00 PM
Inflammation to Maintain Health
5:00–7:00 PM
Irene Salinas Remiro †, University of New Mexico
Evolution of Neuroimmune Systems
Evolution of Neuroimmune Systems
Josephine W. Thinwa †, University of Texas Southwestern Medical Center
Protection Against Neurotropic Viruses
Protection Against Neurotropic Viruses
Robyn S Klein, Western University, London, Ontario
Host-Pathogen Neuroimmunology Gone Wrong
Host-Pathogen Neuroimmunology Gone Wrong
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, June 24, 2026
Breakfast
7:00–8:00 AM
CNS Glia and Neuroinflammation
8:00–9:30 AM
Michael V. Sofroniew, University of California, Los Angeles
Astrocytes and CNS Innate Immunity
Astrocytes and CNS Innate Immunity
Ukpong Bassey Eyo †, University of Virginia
Microglia and Neuroinflammation
Microglia and Neuroinflammation
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
CNS Glia, Neuroinflammation and Behavior
9:30–11:00 AM
Marie-Ève Tremblay, University of Victoria
Microglia, Sex Differences, Neuroinflammation and Psychiatric Disorders
Microglia, Sex Differences, Neuroinflammation and Psychiatric Disorders
Short Talk(s) Chosen from Abstracts
Poster Setup
11:00–1:00 PM
On Own for Lunch
11:00–5:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable (Joint)
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Gut and Systemic Influences on CNS Inflammation, Neurodegeneration and Behavior
5:00–7:00 PM
Laura M. Cox, Harvard Medical School
Gut Microbiome, Autoimmunity and Neurodegeneration
Gut Microbiome, Autoimmunity and Neurodegeneration
Andrea Merchak †, Indiana University
Microbial Metabolites and Immune Regulation
Microbial Metabolites and Immune Regulation
Eleonore Beurel †, University of Miami
Stress, Inflammation, Microbiome and Depression
Stress, Inflammation, Microbiome and Depression
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Thursday, June 25, 2026
Breakfast
7:00–8:00 AM
Drug Delivery (Joint)
8:00–11:00 AM
Fiona C. Elwood †, Janssen R&D
Developing Drugs for CNS Disorders: Considerations for Therapies That Cross the BBB
Developing Drugs for CNS Disorders: Considerations for Therapies That Cross the BBB
Kate Monroe, Denali Therapeutics
Human Genetics Identifies Novel Microglial Targeting Therapeutic Approaches for Alzheimer's Disease
Human Genetics Identifies Novel Microglial Targeting Therapeutic Approaches for Alzheimer's Disease
Speaker to be Announced
Michele Bronson †, Ventus Therapeutics
Targeting NLRP3 for Neuroinflammation and Neurodegeneration (Mechanism and Trials)
Targeting NLRP3 for Neuroinflammation and Neurodegeneration (Mechanism and Trials)
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Roundtable Discussion: Neuroinflammation and Psychiatric/Behavioral Disorders
2:30–4:30 PM
Marie-Ève Tremblay, University of Victoria
Eleonore Beurel †, University of Miami
Valeria Mondelli †, King's College London
Coffee Available
4:30–5:00 PM
Blood-Brain Barrier and Inflammation
5:00–6:15 PM
Catherine Hall †, University of Sussex
Neurovascular Function and Neuroinflammation
Neurovascular Function and Neuroinflammation
Andy Shih †, Seattle Children’s Research Institute and University of Washington
Brain Capillary Function in Neuroinflammation
Brain Capillary Function in Neuroinflammation
Short Talk(s) Chosen from Abstracts
Closing Keynote Address
6:15–7:00 PM
Jenny P.Y. Ting, University of North Carolina at Chapel Hill
Innate Immune Receptors in Neuroinflammation
Innate Immune Receptors in Neuroinflammation
Meeting Wrap-Up: Outcomes and Future Directions
7:00–7:15 PM
Social Hour with Lite Bites
7:15–8:15 PM
Entertainment
8:00–11:00 PM
Cash Bar
8:00–11:00 PM
Friday, June 26, 2026
Departure
12:00–11:59 PM
Subscribe for Updates